Therapeutic Efficacy of Injectable Hydrogel Systems in Mice Tumor Models
David R. Elmaleh(Harvard University), Salomon M. Stemmer(Tel Aviv University)
Cited by 0
Related Papers
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation
|Journal of Clinical Oncology|2014|1.7k
Imaging amyloid deposition in Lewy body diseases
|Neurology|2008|446
Efficacy and safety of olaparib monotherapy in germline BRCA1 / 2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy
|Gynecologic Oncology|2015|300
Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer
|JAMA Oncology|2021|291
A Phamacoeconomic Analysis of Personalized Dosing vs Fixed Dosing of Pembrolizumab in Firstline PD-L1-Positive Non–Small Cell Lung Cancer
|JNCI Journal of the National Cancer Institute|2017|102